4-Chloro-2-(2,6-dioxopiperidin-3-yl)-1H-pyrrolo[3,4-c]pyridine-1,3(2H)-dione, 97%, 100mg

(R)-tert-Butyl 3-benzyl-3-(1,2,2-trimethylhydrazinecarbonyl)piperidine-1-carboxylate, 97%, 1g

ETHYL 2-AMINO-6-CHLORONICOTINATE, 95.0%, 250mg

Methyl2-(3-azabicyclo[3.2.1]octan-8-yl)acetate;hydrochloride, 98%, 5g

2-Amino-4,5-dimethyl-1-phenyl-1H-pyrrole-3-carbonitrile, 95.0%, 1g

2-BROMO-8-METHOXYQUINOLINE, 95.0%, 1g

N,N-Diethyl-N-methyl-2-((3-methyl-2-phenylpentanoyl)oxy)ethanaminium bromide, 95.0%, 250mg

Methyl (S)-2-((tert-butoxycarbonyl)amino)-3-((S)-2-oxopyrrolidin-3-yl)propanoate, 95%, 1g

Matraz de fondo redondo con junta esmerilada estándar 1000 ml NS 29/32

2-Nitrotoluene>99.0%(GC)25g

7-oxo-4,7-dihydro[1,2,4]triazolo[1,5-a]pyrimidine-6-carboxylic acid, 95.0%, 5g

3-Chloro-6-isopropoxypyridazine, 95.0%, 5g

Nalpha-[(9H-Fluoren-9-ylmethoxy)carbonyl]-Nepsilon-tetradecanoyl-L-lysine>98.0%(HPLC)(N)1g